BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31754890)

  • 1. PET Scan: Nuclear Medicine Imaging in Myositis.
    Selva-O'Callaghan A; Gil-Vila A; Simó-Perdigó M; Trallero-Araguás E; Alvarado-Cárdenas M; Pinal-Fernandez I
    Curr Rheumatol Rep; 2019 Nov; 21(11):64. PubMed ID: 31754890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple values of
    Li Y; Zhou Y; Wang Q
    Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications.
    Maliha PG; Hudson M; Abikhzer G; Singerman J; Probst S
    Nucl Med Commun; 2019 Apr; 40(4):377-382. PubMed ID: 30664602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis.
    Owada T; Maezawa R; Kurasawa K; Okada H; Arai S; Fukuda T
    J Rheumatol; 2012 Aug; 39(8):1659-65. PubMed ID: 22753657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MRI in idiopathic inflammatory myopathies: a review article.
    Pilania K; Jankharia B
    Acta Radiol; 2022 Feb; 63(2):200-213. PubMed ID: 33554607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis.
    Selva-O'Callaghan A; Grau JM; Gámez-Cenzano C; Vidaller-Palacín A; Martínez-Gómez X; Trallero-Araguás E; Andía-Navarro E; Vilardell-Tarrés M
    Am J Med; 2010 Jun; 123(6):558-62. PubMed ID: 20569766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis.
    Kundrick A; Kirby J; Ba D; Leslie D; Olsen N; Foulke G
    Semin Arthritis Rheum; 2019 Aug; 49(1):140-144. PubMed ID: 30482435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of
    Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
    J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
    [No Abstract]   [Full Text] [Related]  

  • 9. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis.
    Tanaka S; Ikeda K; Uchiyama K; Iwamoto T; Sanayama Y; Okubo A; Nakagomi D; Takahashi K; Yokota M; Suto A; Suzuki K; Nakajima H
    Rheumatology (Oxford); 2013 Jul; 52(7):1271-8. PubMed ID: 23479721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular ultrasound in idiopathic inflammatory myopathies of adults.
    Reimers CD; Fleckenstein JL; Witt TN; Müller-Felber W; Pongratz DE
    J Neurol Sci; 1993 May; 116(1):82-92. PubMed ID: 8509807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer screening in idiopathic inflammatory myopathies: Ten years experience from a single center.
    Trallero-Araguás E; Gil-Vila A; Martínez-Gómez X; Pinal-Fernández I; Alvarado-Cardenas M; Simó-Perdigó M; Selva-O'Callaghan A
    Semin Arthritis Rheum; 2022 Apr; 53():151940. PubMed ID: 35051890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
    Askanas V; Engel WK; Mirabella M
    Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review.
    Bentick G; Fairley J; Nadesapillai S; Wicks I; Day J
    Semin Arthritis Rheum; 2022 Dec; 57():152107. PubMed ID: 36335683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies.
    Park JH; Olsen NJ
    Curr Rheumatol Rep; 2001 Aug; 3(4):334-45. PubMed ID: 11470053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Sun L; Dong Y; Zhang N; Lv X; Chen Q; Wei W
    Exp Ther Med; 2018 Jun; 15(6):5023-5028. PubMed ID: 29805526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies.
    Day JA; Bajic N; Gentili S; Patel S; Limaye V
    Muscle Nerve; 2019 Nov; 60(5):549-557. PubMed ID: 31397909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is (18)F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis?
    Pipitone N; Versari A; Salvarani C
    J Rheumatol; 2013 Jan; 40(1):91. PubMed ID: 23280166
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic Imaging of Inflammatory Myopathies: New Concepts and a Radiological Approach.
    Guimarães JB; Nico MA; Omond AG; Aivazoglou LU; Jorge RB; Zanoteli E; Fernandes ARC
    Curr Rheumatol Rep; 2019 Feb; 21(3):8. PubMed ID: 30762122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging tools for the clinical assessment of idiopathic inflammatory myositis.
    Walker UA
    Curr Opin Rheumatol; 2008 Nov; 20(6):656-61. PubMed ID: 18946324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.